Today's News from the Lawmakers
CCHR Condemns FDA's Approval of Electricity-Zapping for 'ADHD' Kids
Source: The Ponder News
May 1, 2019
The Food and Drug Administration (FDA) has approved a device to zap a low-level electrical pulse through the forehead of 7-12 year olds as treatment for Attention Deficit Hyperactivity Disorder (ADHD).[1] But the mental health watchdog, Citizens Commission on Human Rights International (CCHR), says with concern that some psychiatrists have now turned to the FDA to approve a device that "electro-shocks children into docility."
Read more...
FDA permits marketing of first medical device for treatment of ADHD
Source: The Ponder News
April 22, 2019
The U.S. Food and Drug Administration has permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, is indicated for patients ages 7 to12 years old who are not currently taking prescription ADHD medication and is the first non-drug treatment for ADHD granted marketing authorization by the FDA.
No comments:
Post a Comment